Patent ID: 9738942
Date: 2017-08-22
CPC Classifications: A61K,A61P,C12Q,G01N

Claim:
1. A method for treating hepatitis C of a patient according to evaluating a therapeutic efficacy of interferon (IFN)/ribavirin (RBV) on inhibiting a hepatitis C virus, comprising the steps of: providing a specimen of the patient containing a microRNA Let-7g (miRNA Let-7g); mixing the specimen containing the miRNA Let-7g, a primer of the miRNA Let-7g and a polymerase chain reaction (PCR) reagent altogether; performing a quantitative real time PCR on the miRNA Let-7g using the primer and the PCR reagent to obtain a CT(Let-7g) value: evaluating the therapeutic efficacy of IFN/RBV on inhibiting the hepatitis C virus according to an expressing level of the miRNA Let-7g in the specimen, wherein the expressing level of miRNA Let-7g is represented by LOG 10(2 administering an effective amount of IFN/RBV to the patient that the therapeutic efficacy of IFN/RBV on inhibiting the hepatitis C virus is confirmed.